The LepR–STAT3 signaling pathway, known to mediate the major part of leptin action on body weight and glucose homeostasis, is required for leptin action in reducing T1D hyperglycemia7, although other signaling pathways may also play a role23. This evidence concerns the gene LEPR and type 1 diabetes mellitus.